Literature DB >> 2171458

Mutagenic activity of BKV and JCV in human and other mammalian cells.

M Theile1, G Grabowski.   

Abstract

We present data suggesting that human polyomaviruses BKV and JCV, widely distributed throughout human populations, are able to induce gene mutations in cultured cells. In this study, using different infecting agents, cell lines to be infected, mutation expression periods, and selection systems, we observed mutagenic effects of varying extent with values of spontaneous mutant frequencies being increased after BKV infection up to 100-fold in BHK cells (6-thioguanine resistance) and nearly 35-fold in virus-transformed human Lesch-Nyhan cells (ouabain resistance). In experiments with BKV the viral mutagenic potential was found to be raised both in moderately uv-irradiated cells, or when wild-type virus was replaced by the variant BKV-IR isolated from a human tumor. Since BKV-IR is defective in the expression of small-t antigen, the viral mutagenicity does not require this protein to be active. BKV was shown to mutate, besides different established cell lines, human peripheral blood lymphocytes. Moreover, as demonstrated by comparing mutagenicities of DNAs from BKV, JCV, and the related polyomavirus SV40, the mutagenic effects of the three viruses do not appear to be essentially different. Implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171458     DOI: 10.1007/BF01316675

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  S A Houff; E O Major; D A Katz; C V Kufta; J L Sever; S Pittaluga; J R Roberts; J Gitt; N Saini; W Lux
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

3.  A comparison of the radiation-induced mutation at the HGPRT locus in V79 and BHK cells.

Authors:  G J Cambray; C J Roberts; S K Carver; P D Holt
Journal:  Mutat Res       Date:  1987-02       Impact factor: 2.433

4.  Prevalence in Italy of antibodies to a new human papovavirus (BK virus).

Authors:  M Portolani; A Marzocchi; G Barbanti-Brodano; M La Placa
Journal:  J Med Microbiol       Date:  1974-11       Impact factor: 2.472

5.  Comparison between mutagenesis in normal and transformed Syrian hamster fibroblasts: difference in the temporal order of HPRT gene replication.

Authors:  T Tsutsui; B D Crawford; P O Ts'o; J C Barrett
Journal:  Mutat Res       Date:  1981-02       Impact factor: 2.433

6.  Restricted replication of BK virus in human lymphocytes.

Authors:  M Portolani; M Piani; G Gazzanelli; M Borgatti; A Bartoletti; M P Grossi; A Corallini; G Barbanti-Brodano
Journal:  Microbiologica       Date:  1985-01

7.  Molecular and biological properties of BK virus-IR, a BK virus variant isolated from a human tumor.

Authors:  M Pagnani; M Negrini; P Reschiglian; A Corallini; P G Balboni; S Scherneck; G Macino; G Milanesi; G Barbanti-Brodano
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes.

Authors:  R J Albertini; L M Sullivan; J K Berman; C J Greene; J A Stewart; J M Silveira; J P O'Neill
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

9.  Expression of viral early functions in rat 3Y1 cells infected with human papovavirus BK.

Authors:  S Watanabe; Y Yogo; K Yoshiike
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  Immortalization of human Lesch-Nyhan-fibroblasts following infection with Simian virus 40.

Authors:  L Lübbe; M Rudolph; S Scherneck; W Zimmermann; E Geissler
Journal:  Arch Geschwulstforsch       Date:  1983
View more
  9 in total

1.  Alterations of DNA damage repair pathways resulting from JCV infection.

Authors:  Armine Darbinyan; Martyn K White; Selma Akan; Sujatha Radhakrishnan; Luis Del Valle; Shohreh Amini; Kamel Khalili
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

2.  BK virus as a cofactor in the etiology of prostate cancer in its early stages.

Authors:  Dweepanita Das; Kirk Wojno; Michael J Imperiale
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

Review 3.  NAD+ homeostasis in health and disease.

Authors:  Mario Romani; Dina Hofer; Elena Katsyuba; Johan Auwerx
Journal:  Nat Metab       Date:  2020-01-20

4.  An immunohistochemical study of p53 and proliferating cell nuclear antigen expression in progressive multifocal leukoencephalopathy.

Authors:  G A Lammie; A Beckett; R Courtney; F Scaravilli
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 5.  JC virus: an oncogenic virus in animals and humans?

Authors:  Melissa S Maginnis; Walter J Atwood
Journal:  Semin Cancer Biol       Date:  2009-02-24       Impact factor: 15.707

Review 6.  BK virus and human cancer: innocent until proven guilty.

Authors:  Johanna R Abend; Mengxi Jiang; Michael J Imperiale
Journal:  Semin Cancer Biol       Date:  2009-02-21       Impact factor: 15.707

7.  Analysis of the excreted JC virus strains and their potential oral transmission.

Authors:  Sílvia Bofill-Mas; Pilar Clemente-Casares; Eugene O Major; Blanche Curfman; Rosina Girones
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

8.  New insights on the association between the prostate cancer and the small DNA tumour virus, BK polyomavirus.

Authors:  Mauro Tognon; Maurizio Provenzano
Journal:  J Transl Med       Date:  2015-12-23       Impact factor: 5.531

Review 9.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.